News | Cath Lab | July 07, 2017

Patient Race, Gender Both Important in Predicting Heart Attack Symptoms in the ER

A study looking at thousands of patients who came to the emergency department with chest pain found that different symptoms matter more and less in black and white men and women when it comes to predicting heart attacks

Patient Race, Gender Both Important in Predicting Heart Attack Symptoms in the ER

July 7, 2017 — Researchers at the George Washington University (GW) found that certain symptoms are more and less predictive of patients’ risk for acute coronary syndrome (ACS), which includes heart attack, in patients of different gender and race.

“When people come to the emergency department with chest pain or shortness of breath, emergency physicians must diagnose the cause. Classic symptoms of heart attack include pain in the center of the chest, shortness of breath, sweatiness and pain that goes down the left arm. Prior research showed that females, older adults and people with conditions such as diabetes do not show these classic symptoms,” said Jesse Pines, M.D., senior author and director of the Center for Healthcare Innovation and Policy Research at the GW School of Medicine and Health Sciences. “We wanted to know how different combinations of race and gender play into this.  Our overall goal was to better pinpoint what predicts these non-classic presentations of ACS.”

Pines and his research team found that while these classic symptoms, such as chest pain, can be helpful in determining which symptoms represent a heart attack, symptoms are differently predictive in varying genders and races. For example, white males and black females present with more classic symptoms of heart attack. By contrast, the only predictive symptom in black males was sweatiness. For white women, symptoms were not helpful at all.

The study, published in the Emergency Medicine Journal, looked at 4,162 emergency department patients with chest pain enrolled between 1999 and 2008. The GW research team looked at the association between 24 chest pain symptoms and 30-day ACS, and adjusted for age and cardiovascular comorbidities. In black males, only diaphoresis — excessive, abnormal sweating — was associated with ACS, while in white males, left arm pain, pressure/tightness and pain just below the sternal bone were associated with ACS. In black females, diaphoresis, as well as palpitations and left arm pain were associated with ACS, while chest pain and left anterior chest pain lowered ACS risk. No symptoms predicted ACS in white females.

Chest pain is the second most common presenting complaint in U.S. emergency departments, accounting for 7 million visits each year. Missing diagnosis of heart attack is the top reason emergency medicine physicians are named in malpractice cases. This study will give physicians better guidance on understanding which symptoms matter more for which groups to better distinguish patients with serious emergencies.

“All four subgroups, white males, black males, white females and black females, all present with heart attack differently,” said Ahmed Allabban, M.D., first author and emergency medicine resident at the GW School of Medicine and Health Sciences. “It is important for emergency medicine physicians to know that symptoms matter less for white women and black men and are more important for white men and black women. We hope this will also help patients to know whether the symptoms they are having should be more or less worrisome.”

Read the article “Race, Gender and Socioeconomic Factors Impact PCI Outcomes.”

Read the article “Greater Emphasis Needed on Preventing, Treating Heart Disease in Women.”

For more information: www.emj.bmj.com

Related Content

Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
NIAID Scientists Illuminate Mechanism of Increased Cardiovascular Risks With HIV
News | Cardiac Diagnostics| September 14, 2017
September 14, 2017 — Scientists at the National Institutes of Health have expanded the understanding of how chronic i
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Overlay Init